2008 | 2007 | 2006 | 2005 | 2004 | 2003
|
| December 5, 2002 |
 Vasogen Reports Positive Results from Pilot Study in Chronic Lymphocytic Leukemia |
 |
| November 19, 2002 |
| FDA Clears Vasogen to Initiate Pivotal Phase III Clinical Trial in Chronic Heart Failure |
|
| November 18, 2002 |
| Vasogen Phase II Chronic Heart Failure Presentation Receives Award at American Heart Association Meeting |
|
| November 12, 2002 |
| Vasogen Receives Notice of Allowance for Key U.S. Patent in Chronic Heart Failure |
|
| November 10, 2002 |
| Vasogen Clinical Results Selected for Oral Presentation at the Annual Scientific Meeting of the Heart Failure Society of America |
|
| October 30, 2002 |
| Vasogen Announces Third Quarter 2002 Results |
|
| September 25, 2002 |
| Vasogen’s Clinical Results Presented at the Scientific Meeting of the Heart Failure Society of America |
|
| September 17, 2002 |
| Vasogen Neuroinflammatory Disease Research Published in the Journal NeuroImmunoModulation |
|
| September 4, 2002 |
| Vasogen Clinical Results in Heart Failure Selected for Oral Presentation at the 2002 Scientific Sessions of the American Heart Association |
|
| July 24, 2002 |
| Vasogen Announces Second Quarter 2002 Results |
|
| July 10, 2002 |
| Vasogen Clinical Results Selected for Oral Presentation at the Annual Scientific Meeting of the Heart Failure Society of America |
|
| June 10, 2002 |
| Vasogen Announces Plans for North American Pivotal Trial in Chronic Heart Failure |
|
| May 30, 2002 |
| Vasogen Cardiovascular Disease Research Published in Atherosclerosis and the European Journal of Vascular and Endovascular Surgery |
|
| May 28, 2002 |
| Vasogen Changes American Stock Exchange Symbol to ‘VSV’ |
|
| May 28, 2002 |
| Vasogen Completes Financing |
|
| May 24, 2002 |
| Vasogen Announces Exercise of Underwriters’ Option |
|
| May 7, 2002 |
| Vasogen Announces $17 Million Bought Deal |
|
| April 11, 2002 |
| Vasogen Announces First Quarter 2002 Results |
|
| March 14, 2002 |
| Vasogen Clinical Trial Identifies Optimal Treatment Schedule in Psoriasis |
|
| March 6, 2002 |
| Vasogen Appoints the President of Quest Diagnostics to its Board of Directors |
|
| February 28, 2002 |
| Vasogen Announces Positive Results from Congestive Heart Failure Trial |
|
| February 7, 2002 |
| Vasogen Announces 2001 Year-End Results |
|
Home 
Contact Us 
Search 
Site Map 
Printable Page